Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
135 studies found for:    new onset type 1 diabetes
Show Display Options
RSS Create an RSS feed from your search for:
new onset type 1 diabetes
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Albiglutide weekly injection;   Biological: Placebo weekly injection;   Biological: Insulin
2 Terminated
Has Results
Study of Antithymocyte Globulin for Treatment of New-onset T1DM
Condition: New-onset Type 1 Diabetes Mellitus
Interventions: Drug: Antithymocyte globulin;   Drug: Placebo
3 Completed Inducing Remission in Type 1 Diabetes With Alefacept
Condition: New-onset Type 1 Diabetes Mellitus
Interventions: Biological: Alefacept;   Drug: Placebo
4 Recruiting New Onset Type 1 Diabetes: Role of Exenatide
Condition: Type 1 Diabetes
Interventions: Drug: Exenatide;   Drug: Rapid and long acting insulin;   Drug: long acting insulin + rapid acting + 1.25 mcg Exenatide
5 Recruiting Phase II-III Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes
Condition: New Onset Type-1 Diabetes
Interventions: Biological: Alpha-1 Antitrypsin;   Other: Placebo
6 Completed Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: pioglitazone;   Drug: Placebo control
7 Recruiting Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: 180 mg/kg Alpha1-PI;   Biological: 90 mg/kg Alpha1-PI;   Biological: Placebo
8 Completed A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: NBI-6024
9 Completed Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: otelixizumab infusion plus physician determined standard of care;   Biological: placebo infusion plus physician determined standard of care
10 Not yet recruiting TCZ in New-onset Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Tocilizumab;   Drug: Placebo for Tocilizumab
11 Completed Immunointervention With Calcitriol in New-Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: 1,25-dihydroxy-vitamin D3 (calcitriol);   Drug: placebo
12 Recruiting Efficacy and Safety Study of Autologous Hematopoietic Stem Cell Transplantation to Treat New Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Procedure: immunosuppression and stem cell transplantation
13 Terminated
Has Results
Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes
Conditions: Diabetes Mellitus Type 1;   Autoimmune Diabetes
Interventions: Drug: Insulin;   Drug: Lansoprazole;   Drug: Sitagliptin;   Biological: Diamyd;   Drug: GAD65 (Diamyd)
14 Not yet recruiting ATG-GCSF in New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globulin (ATG)/Placebo;   Drug: Granulocyte colony stimulating factor (GCSF)
15 Completed Use of a Telehomecare Program for Young Patients With New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Device: Telehomecare (Intelligent Distance Patient Monitoring);   Other: Standard education and follow up at diabetes clinic
16 Withdrawn Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: efalizumab;   Drug: placebo
17 Recruiting Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus
Conditions: Type 1 Diabetes;   Insulin Dependent Diabetes;   Juvenile Onset Diabetes Mellitus;   Autoimmune Diabetes
Intervention: Drug: Vildagliptin
18 Completed Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
19 Completed Anti-Interleukin-1 in Diabetes Action
Condition: Type 1 Diabetes
Interventions: Drug: anakinra;   Drug: saline
20 Completed Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: CTLA-4 Ig;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years